← Back to Clinical Trials
Recruiting NCT07504341

NCT07504341 Physiological Finding in Management of COVID 19 Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07504341
Status Recruiting
Phase
Sponsor St. Martin De Porress Hospital
Condition COVID-19 (Coronavirus Disease 2019)
Study Type OBSERVATIONAL
Enrollment 15,000 participants
Start Date 2026-04
Primary Completion 2027-03-11

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type OBSERVATIONAL
Interventions
physiological parameters

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 15,000 participants in total. It began in 2026-04 with a primary completion date of 2027-03-11.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study utilizes physiological indicators of COVID-19 patients as tools for assessing, tracking, worsening, and improving the clinical symptoms of COVID-19 patients. This study employs simple and easy-to-use assessment methods, which can be further aided by artificial intelligence technology to facilitate early response and medication.

Eligibility Criteria

Inclusion Criteria: * Reviewing the patient's medical history, the primary focus was on hospital records and existing physiological parameters such as blood pressure, heart rate, respiratory rate, and level of consciousness. The patient received treatment at the hospital between May 2022 and March 2027 Exclusion Criteria: * Excluding patients with incomplete clinical data or missing information in their medical records.

Contact & Investigator

Central Contact

Chia-Hsi Chen, Physician

✉ urologist3509@gmail.com

📞 886-5-2756000

Principal Investigator

Chia-Hsi Chen, Physician

PRINCIPAL INVESTIGATOR

St. Martin De Porress Hospital

Frequently Asked Questions

Who can join the NCT07504341 clinical trial?

This trial is open to participants of all sexes, studying COVID-19 (Coronavirus Disease 2019). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07504341 currently recruiting?

Yes, NCT07504341 is actively recruiting participants. Contact the research team at urologist3509@gmail.com for enrollment information.

Where is the NCT07504341 trial being conducted?

This trial is being conducted at Chiayi City, Taiwan, Tainan, Taiwan.

Who is sponsoring the NCT07504341 clinical trial?

NCT07504341 is sponsored by St. Martin De Porress Hospital. The principal investigator is Chia-Hsi Chen, Physician at St. Martin De Porress Hospital. The trial plans to enroll 15,000 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology